I am a recent investor in EBR (today) and I am confident in the product. I traditionally purchase shares based on where they are in FDA trials. This company is a little different, as the timelines are not as clear. Can anyone direct me as to where the catalysts are for this companies launch of its product particularly into the US market? When would this be expected, and is there literature on this?
Thanks and all the best!
I am a recent investor in EBR (today) and I am confident in the...
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
-0.010(1.17%) |
Mkt cap ! $307.6M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.0¢ | 83.5¢ | $694.8K | 820.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29597 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 13701 | 3 |
View Market Depth
| Last trade - 15.48pm 04/10/2024 (20 minute delay) ? |
| EBR (ASX) Chart |